Citicoline as Neuroprotector in Preterm

• Status: Recruiting
• Trial end date: 2028-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Citicoline as neuroprotector in preterm

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sherief Abd-Elsalam
• Treatments: Cytidine Diphosphate Choline

Criteria

Inclusion Criteria:

• Preterm on CPAP or ventilator

Exclusion Criteria:

• Multiple congenital anomalies